CD4 and myeloid sarcoma: Under the same conditions, in contrast, GA did not reduce the levels of IL-10 or IL-4, representative MS-associated Th2 cytokines, in LPS-treated CD4+ T cells with glia (Fig. 10B)38, 39, 40, 41.